AstraZeneca Internal Seroquel Documents Cite Cherry-Picking, Burying Data
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca agreed to unseal internal communications in Seroquel product liability litigation discussing risks associated with the drug.